Turnkey, high-end life sciences space remains in high demand in New Jersey, creating an opportunity for owners of the state’s few remaining legacy pharmaceutical campuses or those that can find other ways to create new space without building speculatively.
Our April edition highlights the ongoing demand from established pharmaceutical firms, startups and a growing pool of international users for high-quality, turnkey laboratory and manufacturing space in New Jersey — and the opportunity for landlords that can provide it.
Merck & Co. has sold its 108-acre campus in Kenilworth to a joint venture of Onyx Equities and Machine Investment Group, with plans to lease back the nearly 2 million-square-foot complex while it relocates in phases over the next several years.
A year after announcing plans to vacate its Kenilworth headquarters, Merck & Co. has officially placed the nearly 2 million-square-foot office and research campus on the market for sale.
Merck & Co. is leaving its Kenilworth headquarters and returning its front office to Rahway, in a move that is slated to take place by the end of 2023.
A property in Kenilworth will serve as a warehouse and shipping point for Tesla vehicles after a newly completed, 14,100-square-foot lease announced by The Blau & Berg Co.
Brokers with CBRE are seeking a buyer for a three-building, 50,000-square-foot industrial complex in Kenilworth, touting its proximity to Port Newark-Elizabeth and a lack of comparable properties in the immediate area.
